These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3831992)

  • 21. [The effect of quinidine on digoxin plasma levels after discontinuation of digoxin therapy].
    Markuljak I; Kvĕtenský J; Licko V; Dvorský J; Funiak S; Záhradný V
    Vnitr Lek; 1990 Jan; 36(1):70-4. PubMed ID: 2327086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral amiodarone in high-risk ventricular arrhythmias.
    Toruncha A; García-Barreto D; González-Gómez A; Llerena L; Sellén J; Ramos-Emperador C; Cabrera-Alonso C; Hernández-Cañero A
    Cor Vasa; 1982; 24(5):354-64. PubMed ID: 7172689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Monitoring of anti-arrhythmia drugs with the Holter system and the determination of their blood levels (mexiletine (mexitil) and amiodarone)].
    Paciaroni E; Ferroni C; Marini M; Campanari G
    Minerva Cardioangiol; 1985 May; 33(5):251-8. PubMed ID: 4033966
    [No Abstract]   [Full Text] [Related]  

  • 24. Amiodarone-digoxin interaction. Clinical and experimental observations.
    Oetgen WJ; Sobol SM; Tri TB; Heydorn WH; Rakita L
    Chest; 1984 Jul; 86(1):75-9. PubMed ID: 6734297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological and clinical research on the interaction of digitalis and amiodarone in heart disease patients with varying degrees of cardiac insufficiency].
    Fornaro G; Rossi P; Padrini R; Piovan D; Ferrari M; Fortina A; Tomassini G; Aquili C
    G Ital Cardiol; 1984 Dec; 14(12):990-8. PubMed ID: 6532895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Low-dose amiodarone therapy in the treatment of therapy-refractory complex ventricular arrhythmias].
    Jost M; Hoffmann A; White RA; Burckhardt D
    Cardiology; 1983; 70 Suppl 1():122-8. PubMed ID: 6850692
    [No Abstract]   [Full Text] [Related]  

  • 27. Intravenous amiodarone in the treatment of various arrhythmias following cardiac operations.
    Installe E; Schoevaerdts JC; Gadisseux P; Charles S; Tremouroux J
    J Thorac Cardiovasc Surg; 1981 Feb; 81(2):302-8. PubMed ID: 7453241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amiodarone for refractory cardiac arrhythmias: 10-year study.
    Leak D; Eydt JN
    CMAJ; 1986 Mar; 134(5):495-501. PubMed ID: 3948063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digoxin toxicity associated with amiodarone therapy in children.
    Koren G; Hesslein PS; MacLeod SM
    J Pediatr; 1984 Mar; 104(3):467-70. PubMed ID: 6707801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experience with intravenous amiodarone in hyperkinetic supraventricular arrhythmias].
    Ricevuti A; Bianchi C; Bonifazi C; Coppetti S; Ferrari O; Rinaldo R; Rizzi M; Tavecchi L; Zampaglione G; Ziletti G; Distante S
    G Ital Cardiol; 1981; 11(6):812-9. PubMed ID: 7319187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-arrhythmic action of combinations of trimecaine with quinidine, novocainamide and cordaron (clinico-experimental study)].
    Oleĭnikov VE; Tatarchenko IP; Zhivotovskaia GG
    Kardiologiia; 1985 Sep; 25(9):118-20. PubMed ID: 2416980
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety of long-term amiodarone in treatment of cardiac arrhythmias: dosage experience.
    Haffajee CI; Love JC; Alpert JS; Asdourian GK; Sloan KC
    Am Heart J; 1983 Oct; 106(4 Pt 2):935-43. PubMed ID: 6613840
    [No Abstract]   [Full Text] [Related]  

  • 33. [Harmful interactions of amiodarone and class I anti-arrhythmia agents].
    Tartini R; Kappenberger L; Steinbrunn W
    Schweiz Med Wochenschr; 1982 Nov; 112(45):1585-7. PubMed ID: 7156952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous amiodarone: UK clinical experience survey.
    Gosling RH; Wildey S; Wirth MA
    Br J Clin Pract Suppl; 1986 Apr; 44():147-51. PubMed ID: 3089254
    [No Abstract]   [Full Text] [Related]  

  • 35. [Amiodarone-flecainide combination in the treatment of severe ventricular arrhythmia].
    Fontaine G; Frank R; Tonet JL
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1421-2. PubMed ID: 6439167
    [No Abstract]   [Full Text] [Related]  

  • 36. Optimizing oral dosing and monitoring of noncardiac toxicities with chronic amiodarone therapy.
    Tsikouris JP; White CM; Kluger J
    Conn Med; 2000 Jan; 64(1):35-8. PubMed ID: 10697362
    [No Abstract]   [Full Text] [Related]  

  • 37. Amiodarone--a new type of antiarrhythmic drug.
    Drug Ther Bull; 1981 Oct; 19(22):86-8. PubMed ID: 7285808
    [No Abstract]   [Full Text] [Related]  

  • 38. [Amiodarone: pharmacology, clinical use and side effects].
    Popiliev I
    Vutr Boles; 1985; 24(5):17-25. PubMed ID: 3911581
    [No Abstract]   [Full Text] [Related]  

  • 39. [Anti-anginous activity of the amiodarone-practolol combination].
    Antonelli G; Franchini G; Cristallo E; Cesaro S
    Boll Soc Ital Cardiol; 1973; 18(3):232-5. PubMed ID: 4807063
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of amiodarone on oral digoxin bioavailability in healthy volunteers.
    Maragno I; Santostasi G; Gaion RM; Paleari C
    Int J Clin Pharmacol Res; 1984; 4(2):149-53. PubMed ID: 6469441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.